Novel genetic approach to investigate the role of plasma secretory phospholipase A2 (sPLA2)-V isoenzyme in coronary heart disease: modified Mendelian randomization analysis using PLA2G5 expression levels.

MLA

Holmes, Michael V., et al. “Novel Genetic Approach to Investigate the Role of Plasma Secretory Phospholipase A2 (SPLA2)-V Isoenzyme in Coronary Heart Disease: Modified Mendelian Randomization Analysis Using PLA2G5 Expression Levels.” Circulation. Cardiovascular Genetics, vol. 7, no. 2, Apr. 2014, pp. 144–50. EBSCOhost, https://doi.org/10.1161/CIRCGENETICS.113.000271.

APA

Holmes, M. V., Exeter, H. J., Folkersen, L., Nelson, C. P., Guardiola, M., Cooper, J. A., Sofat, R., Boekholdt, S. M., Khaw, K.-T., Li, K.-W., Smith, A. J. P., Van’t Hooft, F., Eriksson, P., Franco-Cereceda, A., Asselbergs, F. W., Boer, J. M. A., Onland-Moret, N. C., Hofker, M., Erdmann, J., … Talmud, P. J. (2014). Novel genetic approach to investigate the role of plasma secretory phospholipase A2 (sPLA2)-V isoenzyme in coronary heart disease: modified Mendelian randomization analysis using PLA2G5 expression levels. Circulation. Cardiovascular Genetics, 7(2), 144–150. https://doi.org/10.1161/CIRCGENETICS.113.000271

Chicago

Holmes, Michael V, Holly J Exeter, Lasse Folkersen, Christopher P Nelson, Montse Guardiola, Jackie A Cooper, Reecha Sofat, et al. 2014. “Novel Genetic Approach to Investigate the Role of Plasma Secretory Phospholipase A2 (SPLA2)-V Isoenzyme in Coronary Heart Disease: Modified Mendelian Randomization Analysis Using PLA2G5 Expression Levels.” Circulation. Cardiovascular Genetics 7 (2): 144–50. doi:10.1161/CIRCGENETICS.113.000271.